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a b s t r a c t
Idiopathic chondrolysis of the hip is a rare condition of unknown etiology characterized by 
progressive destruction of the hyaline cartilage that covers the femoral head and acetabu-
lum. Idiopathic chondrolysis of the hip has an insidious beginning and affects more often 
female adolescents. Patients report severe hip pain, mobility limitation, and even claudi-
cation. This study aimed at reporting one case of that rare disease: an 11-year-old female 
adolescent with chondrolysis, followed up for three years. Infl ammatory activity tests were 
normal. Imaging tests (radiography, ultrasonography and magnetic resonance) were essen-
tial for the diagnosis. The treatment was based on pain control and preservation of the 
joint mobility, and included low-impact physical activity, non-steroidal anti-infl ammatory 
drugs, and disease-modifying antirheumatic drugs, with good response after 12 months of 
treatment. Surgery was not necessary.
© 2013 Elsevier Editora Ltda. All rights reserved.
Condrólise de quadril em uma adolescente: evolução clínica e radiológica
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Condrólise idiopática de quadril
r e s u m o
A condrólise idiopática de quadril  é uma condição rara, caracterizada por destruição pro-
gressiva da cartilagem articular da cabeça do fêmur e do acetábulo, sem etiologia conheci-
da. A CIQ tem início insidioso e acomete com maior frequência meninas na adolescência. 
Os pacientes apresentam dor intensa em quadril, restrição de movimentação e até claudi-
cação. O objetivo do trabalho foi demonstrar um caso dessa doença rara: uma adolescente 
de 11 anos de idade, com condrólise, em acompanhamento por três anos. As provas de 
atividade infl amatória eram normais. Os exames de imagem (radiografi a, ultrassonografi a 
e ressonância magnética) foram essenciais para o diagnóstico. O tratamento baseou-se no 
controle da dor e preservação da mobilidade articular, incluindo atividades físicas de baixo 
impacto, anti-infl amatórios não hormonais e droga modifi cadora de doença, com boa res-
posta após um ano de tratamento. Intervenção cirúrgica não foi necessária.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
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Introduction
Idiopathic chondrolysis of the hip (ICH) is a rare condition 
of unknown etiology characterized by narrowing of the joint 
space caused by the progressive destruction of the hyaline 
cartilage that covers the femoral head and acetabulum.1
In the literature, the description of ICH in the pediatric age 
group is rare, being mostly restricted to case reports.2–6 Chon-
drolysis can occur as an apparently idiopathic event or be sec-
ondary to other hip pathologies.7
The most common causes of secondary chondrolysis are 
as follows: prolonged immobilization; neoplasias; Legg-Calvé-
Perthes disease (avascular necrosis of the femoral head); trau-
ma; septic arthritis; juvenile idiopathic arthritis (JIA); Stickler 
syndrome; and slipped upper femoral epiphysis. 
Idiopathic chondrolysis of the hip most frequently affects 
female adolescents (80%) of Asian or African ethnicity, and is 
more commonly monoarticular (60% affects the right side).3,8 
Bilateral ICH occurs in 5% of the cases.3,8 It is clinically char-
acterized by severe pain in the hip, knee or the entire lower 
limb, mobility limitation, and claudication. Shortening of the 
limb might result. 
The differential diagnosis of ICH is diffi cult to be made, 
mainly with JIA. However, ICH lacks systemic symptoms and 
has normal laboratory fi ndings (hematological, microbiologi-
cal, immunological, and acute phase markers).7 In addition, the 
sole involvement of the hip joint is not frequent in JIA.
In juvenile ICH, the radiological images are useful to ex-
clude secondary causes.3 Magnetic resonance imaging plays an 
important role in the diagnosis and follow-up of that disease.8,9
Some authors have speculated on a genetic and hormonal 
(girls) etiology, but such hypotheses have not yet been con-
fi rmed.10,11 Morrissy et al.12 have suggested that ICH, similarly 
to slipped upper femoral epiphysis, could represent a sero-
negative type of immune response, because its joint space 
narrowing is similar to that of JIA.12 Other authors have dem-
onstrated that antibodies and immune complexes in the 
synovial fl uid could play an important role in the develop-
ment of chondrolysis.13–16 Thus, although the treatment is still 
debated and literature evidence lacks, non-steroidal anti-
infl ammatory drugs and disease-modifying antirheumatic 
drugs are used. The use of biologics, such as anti-TNF-alpha 
agents, has been limited to a case report.10
In severe cases, when there is no response to clinical treat-
ment, cutaneous traction can be used, in addition to surgery. 
The major indications of those procedures are improvement of 
pain and of the hip range of motion, and correction of the de-
formity.10 The surgical treatment includes capsulectomy with 
or without psoas and/or adductor tenotomy, hip arthrodesis 
and arthroplasty, but the results are not promising.11,17 Physical 
therapy is an important measure in the treatment. According 
to the literature, remission occurs in 54% of the cases.9
Because of the scarcity of reports on ICH in the pediatric 
age group, we describe the case of an 11-year-old female ado-
lescent.
Case report
The patient is an 11-year-old white female, complaining of pain 
in the left hip and claudication after physical exercise for one 
month and a half. She denied infections and/or trauma. She 
used a non-steroidal anti-infl ammatory drug for one month 
with no improvement. She also denied involvement of other 
joints. The osteoarticular exam revealed pain and limitation to 
external and internal rotation of the left hip joint and limp-
ing gait. Her laboratory tests showed normal complete blood 
count, erythrocyte sedimentation rate of 10 mm in the fi rst 
hour, normal C-reactive protein, and a negative antinuclear 
antibody result. The diagnostic hypothesis of chronic arthritis 
of the left hip was suggested. Naproxen (500 mg/day – 12 mg/
kg/day) was introduced and slit lamp examination performed, 
resulting normal. The tuberculin skin test was negative.
The hip radiography (postero-anterior and Lauenstein 
views) showed mild joint space narrowing and mild osteo-
penia to the left (Fig. 1). Ultrasonography of the hip showed 
synovial thickening and joint effusion to the left. On scintig-
raphy, increased enhancement of the left hip was observed. 
Magnetic resonance imaging showed joint effusion in the left 
hip, a small area of 8 mm of hyposignal in T1 and hypersignal 
in T2 compatible with subchondral edema related to infl am-
matory process, with no cartilaginous lesion (Fig. 2).
The diagnostic hypotheses were as follows: JIA; avas-
cular necrosis; and chondrolysis. There was no response to 
naproxen, which was replaced with indomethacin (50  mg/
day – 1.2 mg/kg/day). After one month with no improvement, 
oral methotrexate (15  mg/week – 0.25  mg/kg/week) was in-
troduced. Indomethacin was maintained, and motor physical 
therapy and swimming were initiated.
After fi ve months, the patient returned to consultation 
with persistent pain, and reported not using methotrexate for 
two months. The physical therapy and swimming were main-
tained. Her physical exam was unaltered. Three months after 
reintroducing methotrexate, the patient returned to consulta-
tion reporting pain on physical exertion and claudication af-
ter that. The methotrexate dose was increased to 20 mg, once 
a week, subcutaneously (0.4 mg/kg/week), the physical thera-
py and swimming were maintained, and new tests requested. 
Six months after reintroducing methotrexate, the patient was 
Fig. 1 – Initial frontal radiography of the pelvis (Lauenstein, 
frog view). Osteopenia of the left hip and mild joint space 
narrowing can be seen.
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asymptomatic, with no claudication. On physical exam, mild 
limitation of her left hip mobility was observed. 
Twelve months later and 24 months of disease progres-
sion, the patient, on regular use of methotrexate, remained 
asymptomatic with no limitation of her left hip mobility. Her 
hip ultrasonography was normal. Her left hip magnetic reso-
nance imaging showed mild lateral subchondral thinning, 
with no edema, and small effusion to the left in T2, showing 
an improvement as compared with the previous exam. Slow 
and progressive reduction in the methotrexate dose was initi-
ated. After three months, the patient returned to consulta-
tion, with no complaints and denying claudication; her physi-
cal exam showed no changes. After four more months with 
no complaints, methotrexate was suspended. The patient is 
well. After a 12-month follow-up with no medication, her left 
hip magnetic resonance imaging showed a small amount of 
synovial fl uid and subchondral and coxofemoral thinning in 
the posterosuperior portion of her hip (burden area), in addi-
tion to mild subchondral edema.
Discussion
We report the case of a female adolescent with chondrolysis, 
whose initial complaint was chronic pain in the left hip with 
claudication. She reported no history of trauma, and had limi-
tation of her hip mobility and normal laboratory tests. After 
receiving methotrexate and undergoing physical therapy, she 
improved. Her disease is currently under remission with no 
medication. 
According to the literature, ICH usually manifests as hip 
pain and/or radiated pain to the knees.2 The diagnosis is clinical 
and radiographic.1 Our patient had monoarticular involvement 
of the hip, as frequently described in the literature.6 In addi-
tion, hers is the most frequently reported joint impairment in a 
female adolescent.3 Functional limitation and limb shortening 
might lead to claudication, if the diagnosis and treatment are 
delayed, which was not the case of our patient.4,12 
The patient’s radiological fi ndings were joint space nar-
rowing and osteopenia. The following radiographic changes 
of ICH are described in the literature: joint space narrowing; 
acetabular protrusion; subchondral cysts; joint erosion; pre-
mature closure of the growth plate; and lateral increase of the 
femoral head.3,6,8,9,12 
The patient’s ultrasonography of the hip showed synovial 
thickening and joint effusion. The magnetic resonance imag-
ing fi ndings of ICH included early subchondral edema, joint 
effusion and bone marrow edema; on the progression, focal 
loss of the cartilage, muscle mass loss and acetabular and 
femoral remodeling occur.7–9
The diagnosis of ICH is diffi cult, requiring the exclusion 
of infl ammatory diseases that progress with monoarthri-
tis.4,8 The most important differential diagnosis is with JIA, 
the most frequent chronic arthritis of childhood. However, 
JIA is hardly ever restricted to the hip, usually affecting other 
joints.18 In addition, the patient had neither laboratory test 
changes (acute phase markers or presence of autoantibodies) 
nor extra-articular manifestations, such as iridocyclitis. In JIA, 
the magnetic resonance imaging shows hypervascular syno-
vial thickening (synovial enhancement), refl ecting intense in-
fl ammatory activity.8 Avascular necrosis of the femoral head, 
epiphysiolysis and neoplasia were excluded based on imaging 
tests. Trauma as a cause of chondrolysis was also ruled out 
because of the long duration of the symptoms and progres-
sion of the fi ndings. Infectious causes, such as tuberculosis, 
should also be excluded.
Van der Hoeven et al.4 have reported the presence of anti-
nuclear antibodies, immune complex deposition and immune 
disorders in some patients, physiopathological factors of ICH 
similar to those of JIA. That fact can justify the treatment with 
drugs usually used to treat JIA, although the literature lacks 
evidence of good response.
The treatment is based on controlling the progression of 
the disease and its symptoms, for whose relief non-steroidal 
anti-infl ammatory drugs are recommended. Disease-modify-
ing antirheumatic drugs, such as methotrexate, are used in 
Fig. 2 – Initial magnetic resonance imaging of the left hip. Coronal plane, T1- and T2-weighed fast spin-echo sequence 
showing moderate joint effusion and a small area with hyposignal in T1 and hypersignal in T2 (arrow), compatible with 
subchondral edema.
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the absence of response to anti-infl ammatory drugs, as was 
the case of our patient.10 Physical therapy and low-impact 
physical activities are additional measures that should be 
associated to drug treatment. Despite the poor adhesion to 
treatment initially, our patient had a good response in the 
nine months following methotrexate reintroduction. Increas-
ing the methotrexate dose was necessary to achieve that good 
response. There was complete reversion of the fi ndings, simi-
larly to that reported in other studies.2,10 We believe that the 
early diagnosis and treatment, and the rapid institution of 
physical therapy were important factors for success.
In addition, the favorable clinical and radiological out-
comes prevented the need for surgery. In a case series of 14 
adolescents with chondrolysis, about 70% required surgery.19 
Of the 14 adolescents assessed, 4 (28%) had a poor outcome.19
Idiopathic chondrolysis of the hip should be considered in 
the differential diagnosis of the monoarticular involvement 
of the hip. Sequelae, such as an expressive reduction in the 
joint cartilage or changes in limb size, can be prevented with 
early treatment.3
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